NICE is having its best week in months — up 13% while most of its software peers head in the opposite direction, a divergence that makes the borrow market's calm reaction all the more striking.
The price move has been sharp. NICE closed at ILS 357.1, a 9.2% gain on Tuesday alone and a 19% advance over the past month. The stock trades on the Tel Aviv Stock Exchange in shekels, and the rally has come entirely on the demand side of the equity market — not from any squeeze pressure in the lending pool. Borrow availability is essentially unconstrained at 1,500%, meaning fifteen shares remain available to lend for every one already borrowed. That reading has loosened further over the past week as borrowing demand falls away. Cost to borrow, running near 0.8%, has drifted lower over both the past week and past month. There is no short-side pressure behind this move.
The contrast with peers underlines how stock-specific the rally is. Close software correlates HUBS and WK fell 5% and 4.6% on Tuesday respectively. dropped 4.4% on the week. The one exception is , which surged 12% on the day and nearly 28% on the week — another contact-center adjacent name catching its own idiosyncratic bid. NICE and FIVN moving together while enterprise software broadly sells off suggests investors are rotating into customer-experience AI names with defensible cloud revenue.
The ORTEX short score reinforces the lack of bearish conviction. At 27.6, the score has been remarkably stable all month — it has barely moved between 26 and 29 across every reading since September 9. A short score in that range means the composite of short interest, cost to borrow, and lending conditions offers no particular signal in either direction. That is consistent with the data: short interest is negligible against a free float with 1,500% availability, and the DTC rank of 84 (days-to-cover near the top of the universe) means any short position would take a long time to unwind against current volume. That is a theoretical risk for shorts, not a live one.
On the ownership side, Brandes Investment Partners and Fidelity International each added over 600,000 shares in the quarter to June — meaningful additions at the 4–5% ownership level. Principal Global Investors is the largest disclosed holder at 7.8% and added a further 92,000 shares as recently as August. The direction of institutional flow is constructive, with the main Israeli domestic funds — Clal, Menora, Artisan — trimming modestly, offset by international buyers adding size. Analyst data on this ticker is too stale to cite (the most recent consensus is from September 2022), so the Street view cannot be reliably characterised here.
The next scheduled catalyst is the Q4 earnings print on November 12. Recent history provides modest guidance: the August 2026 result produced a 0.4% one-day move and a 4.5% five-day gain. The prior quarter delivered a 3.8% one-day drop that extended to a 5.3% loss over five days. The stock's pattern is asymmetric — small beats and modest rallies, harder earnings misses. Heading into November with NICE already 19% higher on the month, the extent to which the current rally is pricing in execution expectations will be the defining question at the next print.
See the live data behind this article on ORTEX.
Open NICE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
